SCHEMBL5838515

SCHEMBL5838515

COCCn1c(C)cn(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCCC3)c2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.43
CNR1 P21554 5/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
CRHBP P24387 1/20 0.35
HTT P42858 1/20 0.35
CRHR2 Q13324 1/20 0.35
SLC6A3 Q01959 1/20 0.34
CNR2 P34972 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838488 0.91 P2RX7 (0.39) P2RX7CNR1MAPTALDH1A1MEN1
SCHEMBL5838925 0.91 P2RX7 (0.36) P2RX7CNR1CRHR2CNR2
SCHEMBL5838989 0.91 P2RX7 (0.47) P2RX7CNR1MAPTALDH1A1SMN1; SMN2
SCHEMBL5843079 0.90 P2RX7 (0.39) P2RX7CNR1MAPTCNR2
SCHEMBL5838192 0.88 P2RX7 (0.37) P2RX7CNR1MAPTCNR2
SCHEMBL5837096 0.87 P2RX7 (0.39) P2RX7CNR1MAPTCNR2
SCHEMBL5839265 0.87 P2RX7 (0.37) P2RX7CNR1MAPTLMNAALDH1A1
SCHEMBL5837095 0.86 P2RX7 (0.38) P2RX7CNR1MAPTCNR2
SCHEMBL5838211 0.86 P2RX7 (0.38) P2RX7CNR1MAPTALDH1A1MEN1
SCHEMBL5838207 0.86 P2RX7 (0.38) P2RX7CNR1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor DOMBROSKI MARK A 2006-09-28 US disclosed
US-7071223-B1 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2006-07-04 US disclosed
EP-1581507-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR Pfizer Products Inc. (US) 2005-10-05 EP disclosed
WO-2004058731-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PRODUCTS INC. (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885CNR1 62/4885MAPT 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.